N'-(3,3,3-trifluoropropyl)butanediamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N'-(3,3,3-trifluoropropyl)butanediamide
• 化学式: C₇H₁₁F₃N₂O₂
• 分子量: 212.17
• InChiKey: BDBIBRDNIFFYLE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  72.2
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160060232A1

  公开（公告）日：2016-03-03

  Disclosed are compounds of Formula (I) or prodrugs thereof; wherein: R 1 is —CH 2 CF 3 or —CH 2 CH 2 CF 3 ; R 2 is —CH 2 CF 3 , —CH 2 CH 2 CF 3 , or —CH 2 CH 2 CH 2 CF 3 ; R 3 is H or —CH 3 ; each R a is independently F, Cl, —CN, —OCH 3 , and/or —NHCH 2 CH 2 OCH 3 ; and z is zero, 1, or 2. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.

  本发明涉及化合物(I)或其前药，其中：R1为—CH2CF3或—CH2CH2CF3；R2为—CH2CF3，—CH2CH2CF3或—CH2CH2CH2CF3；R3为H或—CH3；每个Ra独立地为F、Cl、—CN、—O 和/或—NHCH2CH2O ；z为零，1或2。本发明还涉及使用这些化合物抑制Notch受体的方法，以及包括这些化合物的药物组合物。这些化合物在多种治疗领域，如癌症，中用于治疗、预防或减缓疾病或障碍的进展。
• BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AS NOTCH INHIBITORS
  申请人：Bristol-Myers Squibb Company

  公开号：EP2897945A1

  公开（公告）日：2015-07-29
• [EN] BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AS NOTCH INHIBITORS<br/>[FR] COMPOSÉS BIS(FLUOROALKYL) -1,4-BENZODIAZÉPINONES EN TANT QU'INHIBITEURS DE NOTCH
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2014047372A1

  公开（公告）日：2014-03-27

  Disclosed are compounds of Formula (I) and/or salts thereof: (I) wherein R1 is CH2CH2CF3; R2 is CH2CH2CF3 or CH2CH2CH2CF3; R3 is H, CH3, or Rx; R4 is H or Ry; Ring A is phenyl or pyridinyl; and Rx, Ry, Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer; or as prodrugs of such compounds.